Jacoby Philip R Jr

Avg. Two Year Performance

No purchase track record

49% Avg. Sale Return

22% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(4%)	2%	18%	21%	49%
Sale Success Rate	0 of 5	3 of 5	2 of 5	2 of 5	3 of 5

Osiris Therapeutics, Inc.

Drugs » Biotechnology

Principal Accounting Officer:

Holdings: 12.5K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--